Matches in SemOpenAlex for { <https://semopenalex.org/work/W3154574611> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W3154574611 abstract "Warfarin is traditionally the drug of choice for stroke prophylaxis or treatment of venous thromboembolism in patients with end-stage renal disease (ESRD) on hemodialysis as data on apixaban use is scarce. We aimed to assess the safety and efficacy of Apixaban in patients with ESRD on hemodialysis when compared with warfarin. A comprehensive literature search in PubMed, Google Scholar, and Cochrane databases from inception until Nov 25, 2019, was performed. Studies reporting clinical outcomes comparing Apixaban (2.5 mg BID or 5 mg BID) versus Warfarin in ESRD patients on hemodialysis were included. Mantel-Haenszel risk ratio (RR) random-effects model was used to summarize data. Four studies (three retrospective and one randomized) with a total of 9862 patients (apixaban = 2,547, warfarin = 7315) met inclusion criteria. The overall mean age was 66.6 ± 3.9 years and mean CHA2DS2-VASc score 4.56 ± 0.58. Apixaban was associated with lower rates of major bleeding (RR 0.53, 95% CI 0.45–0.64, p < 0.0001], gastrointestinal (GI) bleed (RR 0.65, 95% CI 0.55–0.76, p < 0.0001), intracranial bleed (RR 0.56, 95% CI 0.36–0.89, p = 0.01), and stroke/systemic embolism [RR 0.65, 95% CI 0.52–0.83, p = 0.0004] compared with warfarin in patients with ESRD on hemodialysis. There was no significant increased risk of all-cause mortality with the apixaban vs. warfarin (RR 0.90, 95% CI 0.41–1.96, p = 0.78). Apixaban had an overall favorable risk-benefit profile, with significant reductions in ischemic stroke, major bleeding, and intracranial bleeding compared to Warfarin in ESRD patients on hemodialysis with non-valvular AF and/or venous thromboembolism." @default.
- W3154574611 created "2021-04-26" @default.
- W3154574611 creator A5001577272 @default.
- W3154574611 creator A5024164661 @default.
- W3154574611 creator A5034828586 @default.
- W3154574611 creator A5042050028 @default.
- W3154574611 creator A5075528598 @default.
- W3154574611 creator A5078241266 @default.
- W3154574611 creator A5082407236 @default.
- W3154574611 creator A5082464182 @default.
- W3154574611 creator A5091734035 @default.
- W3154574611 date "2021-04-01" @default.
- W3154574611 modified "2023-10-17" @default.
- W3154574611 title "Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis" @default.
- W3154574611 cites W1913544684 @default.
- W3154574611 cites W1979423827 @default.
- W3154574611 cites W2098923148 @default.
- W3154574611 cites W2107328434 @default.
- W3154574611 cites W2155524816 @default.
- W3154574611 cites W2158813407 @default.
- W3154574611 cites W2162508946 @default.
- W3154574611 cites W2168106976 @default.
- W3154574611 cites W2588182624 @default.
- W3154574611 cites W2596305759 @default.
- W3154574611 cites W2766283702 @default.
- W3154574611 cites W2790801037 @default.
- W3154574611 cites W2794283332 @default.
- W3154574611 cites W2897495391 @default.
- W3154574611 doi "https://doi.org/10.1016/j.ipej.2021.04.002" @default.
- W3154574611 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8263313" @default.
- W3154574611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33866017" @default.
- W3154574611 hasPublicationYear "2021" @default.
- W3154574611 type Work @default.
- W3154574611 sameAs 3154574611 @default.
- W3154574611 citedByCount "2" @default.
- W3154574611 countsByYear W31545746112023 @default.
- W3154574611 crossrefType "journal-article" @default.
- W3154574611 hasAuthorship W3154574611A5001577272 @default.
- W3154574611 hasAuthorship W3154574611A5024164661 @default.
- W3154574611 hasAuthorship W3154574611A5034828586 @default.
- W3154574611 hasAuthorship W3154574611A5042050028 @default.
- W3154574611 hasAuthorship W3154574611A5075528598 @default.
- W3154574611 hasAuthorship W3154574611A5078241266 @default.
- W3154574611 hasAuthorship W3154574611A5082407236 @default.
- W3154574611 hasAuthorship W3154574611A5082464182 @default.
- W3154574611 hasAuthorship W3154574611A5091734035 @default.
- W3154574611 hasBestOaLocation W31545746111 @default.
- W3154574611 hasConcept C126322002 @default.
- W3154574611 hasConcept C127413603 @default.
- W3154574611 hasConcept C141071460 @default.
- W3154574611 hasConcept C2776301958 @default.
- W3154574611 hasConcept C2778063415 @default.
- W3154574611 hasConcept C2778661090 @default.
- W3154574611 hasConcept C2779161974 @default.
- W3154574611 hasConcept C2780638905 @default.
- W3154574611 hasConcept C2780645631 @default.
- W3154574611 hasConcept C3019040382 @default.
- W3154574611 hasConcept C44249647 @default.
- W3154574611 hasConcept C71924100 @default.
- W3154574611 hasConcept C78519656 @default.
- W3154574611 hasConcept C82789193 @default.
- W3154574611 hasConceptScore W3154574611C126322002 @default.
- W3154574611 hasConceptScore W3154574611C127413603 @default.
- W3154574611 hasConceptScore W3154574611C141071460 @default.
- W3154574611 hasConceptScore W3154574611C2776301958 @default.
- W3154574611 hasConceptScore W3154574611C2778063415 @default.
- W3154574611 hasConceptScore W3154574611C2778661090 @default.
- W3154574611 hasConceptScore W3154574611C2779161974 @default.
- W3154574611 hasConceptScore W3154574611C2780638905 @default.
- W3154574611 hasConceptScore W3154574611C2780645631 @default.
- W3154574611 hasConceptScore W3154574611C3019040382 @default.
- W3154574611 hasConceptScore W3154574611C44249647 @default.
- W3154574611 hasConceptScore W3154574611C71924100 @default.
- W3154574611 hasConceptScore W3154574611C78519656 @default.
- W3154574611 hasConceptScore W3154574611C82789193 @default.
- W3154574611 hasLocation W31545746111 @default.
- W3154574611 hasLocation W31545746112 @default.
- W3154574611 hasOpenAccess W3154574611 @default.
- W3154574611 hasPrimaryLocation W31545746111 @default.
- W3154574611 hasRelatedWork W1923415053 @default.
- W3154574611 hasRelatedWork W1993190469 @default.
- W3154574611 hasRelatedWork W2318491258 @default.
- W3154574611 hasRelatedWork W2327309030 @default.
- W3154574611 hasRelatedWork W2489662481 @default.
- W3154574611 hasRelatedWork W2896204226 @default.
- W3154574611 hasRelatedWork W3028955534 @default.
- W3154574611 hasRelatedWork W34302012 @default.
- W3154574611 hasRelatedWork W4240954712 @default.
- W3154574611 hasRelatedWork W1899149475 @default.
- W3154574611 isParatext "false" @default.
- W3154574611 isRetracted "false" @default.
- W3154574611 magId "3154574611" @default.
- W3154574611 workType "article" @default.